How validated receptor occupancy flow cytometry assays can impact decisions and support drug development
Author:
Affiliation:
1. Biomarkers Department; BioCytex, Marseille; France
2. Sanofi-Aventis Recherche et Développement; DSAR, Head of Biomarkers and Biological Analyses, Vitry-sur-Seine; France
Publisher
Wiley
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Reference36 articles.
1. Federal task force seeks standards for immunotherapy biomarker studies;Finkelstein;J Natl Cancer Inst,2009
2. Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer;Freeman;Mol Cancer,2012
3. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse;Muñoz;Blood,2008
4. SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent anti-tumor activity in models of multiple myeloma and other CD38+ hematologic malignancies;Deckert;Clin Cancer Res,2014
5. Phase1/2 study of lumilixumab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia;Byrd;Blood,2010
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Flow Cytometry: A Versatile and Powerful Tool for Drug Discovery and Development;Pharmedicine Journal;2024-02-29
2. Prediction of standard cell types and functional markers from textual descriptions of flow cytometry gating definitions using machine learning;Cytometry Part B: Clinical Cytometry;2022-03-07
3. Physiological Considerations for Modeling in vivo Antibody-Target Interactions;Frontiers in Pharmacology;2022-02-24
4. Prediction of standard cell types and functional markers from flow cytometry gating definitions using machine learning;2021-08-25
5. A human receptor occupancy assay to measure anti‐PD ‐1 binding in patients with prior anti‐PD ‐1;Cytometry Part A;2021-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3